株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

テルミサルタン市場: 市場機会分析および将来予測

Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

発行 Coherent Market Insights 商品コード 817578
出版日 ページ情報 英文 174 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
テルミサルタン市場: 市場機会分析および将来予測 Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日: 2019年03月01日 ページ情報: 英文 174 Pages
概要

当レポートでは、テルミサルタン(Telmisartan)の世界市場を調査し、市場の概要、タイプ、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の概要

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:含量別
    • 市場スニペット:症状別
    • 市場スニペット:流通チャネル別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場のダイナミクス、規制、および動向分析

  • マーケットダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発
  • パイプライン分析
  • 疫学
  • 歴史的概要
  • 合併と買収
  • 規制シナリオ
  • ファイブフォース分析
  • PEST分析

第4章 テルミサルタン市場:含量別

  • イントロダクション
  • 20mg
  • 40mg
  • 80mg

第5章 テルミサルタン市場:症状別

  • イントロダクション
  • 高血圧
  • 心停止
  • 脳卒中

第6章 テルミサルタン市場:構成別

  • イントロダクション
  • シングル
  • 組み合わせ

第7章 テルミサルタン市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 テルミサルタン市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • アフリカ
  • 中東

第9章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • C.H. Boehringer Sohn AG & Ko. KG
    • Glenmark Generics Inc.
    • Torrent Pharmaceuticals Ltd.
    • Solco Healthcare U.S.
    • Mylan Inc.
    • Aurobindo Pharma Limited
    • Yichang Changjiang Pharmaceutical Co., Ltd
    • Wanbang Biopharmaceuticals
    • Nippon Boehringer Ingelheim Co., Ltd.
    • Company 概要.
  • アナリストの意見

第10章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for therapy of hypertension, in cardiac arrest, and in stroke management. Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term. Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.

Market Dynamics

Prevalence of high blood pressures, is increasing globally attributed to rising geriatric population, chronic disorders such as diabetes, and changing lifestyles which in turn is expected to increase the demand for telmisartan in global market. According to Blood Pressure UK, 2017 update, high blood pressure is the leading cause of heart disease and stroke, killing around 7.5 million people worldwide every year. In 1975, 594 million people were suffering from high blood pressure which increased to 1.1 billion in 2015 and is thought to be due to population growth and an aging population. Thus, rise in geriatric population suffering from high blood pressure is expected to be major factor for growth of telmisartan market in the forecast period.

Furthermore, increasing approvals for Abbreviated new Drug Application (ANDA) for manufacturing of generic telmisartan tablets is propelling growth of telmisartan in the global market. For instance, in July 2014, Glenmark Generics Inc., USA-a subsidiary of Glenmark Generics Limited-received ANDA approval from the U.S. Food and Drug Administration (USFDA) for telmisartan tablets.

Key features of the study:

  • This report provides in-depth analysis of the telmisartan market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global telmisartan market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global telmisartan market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for telmisartan market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
  • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
  • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
  • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Telmisartan Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
      • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
      • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
      • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Glenmark Generics Inc.
    • Torrent Pharmaceuticals Ltd.
    • Solco Healthcare U.S.
    • Aurobindo Pharma Limited
    • Mylan Inc.
    • Yichang Changjiang Pharmaceutical Co., Ltd
    • Wanbang Biopharmaceuticals.
    • Nippon Boehringer Ingelheim Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Strength
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Pipeline Analysis
  • Epidemiology
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Telmisartan Market, By Strength, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • 20mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • 40mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • 80mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Telmisartan Market, By Indication, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cardiac Arrest
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Telmisartan Market, By Composition, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Single
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Combinational
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Telmisartan Market, By Distribution Channel, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

8. Global Telmisartan Market, By Regions, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Composition, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Glenmark Generics Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Torrent Pharmaceuticals Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Solco Healthcare U.S.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mylan Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Aurobindo Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Yichang Changjiang Pharmaceutical Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Wanbang Biopharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Nippon Boehringer Ingelheim Co., Ltd.
    • Company Overview.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top